Cardax

Cardax Days Inventory Outstanding

The Days Inventory Outstanding (DIO) of Cardax (CDXI) as of Oct 19, 2026 is 1,850.69. In the previous year, Days Inventory Outstanding (DIO) was 1,244.64 — a change of 48.69% (higher).

Days Inventory Outstanding

1,850.69

YoY

48.69%

Last updated:

Days Inventory Outstanding (DIO) of Cardax is 2020 1,850.69 . Days Inventory Outstanding (DIO) of Cardax was 2019 1,244.64 . It decreases by 48.69% higher compared to the previous year.

The Cardax Days Inventory Outstanding history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Days Inventory Outstanding
Date
Days Inventory Outstanding
Jan 1, 2016
270.00 USD
Jan 1, 2017
452.30 USD
Jan 1, 2018
772.03 USD
Jan 1, 2019
1,244.64 USD
Jan 1, 2020
1,850.69 USD
The Cardax Days Inventory Outstanding history
YEARDays Inventory OutstandingYoY
1,850.69+48.69%
1,244.64+61.22%
772.03+70.69%
452.30+67.52%
270.00—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Cardax Stock analysis

What does Cardax do? Cardax Inc, a development stage biopharmaceutical company based in Honolulu, Hawaii, focuses on developing pharmaceuticals for chronic diseases driven by inflammation. The company has 10 full-time employees and went public via an IPO on January 30, 2012. Cardax is currently developing two pre-clinical pharmaceutical candidates: CDX-101 and CDX-301. CDX-101 is a proprietary astaxanthin prodrug designed to deliver astaxanthin to the bloodstream following oral administration. Astaxanthin is a naturally occurring molecule known for its anti-inflammatory properties, supporting cardiovascular health, metabolic health, liver health, joint health, and longevity. CDX-301 is a pharmaceutical candidate for macular degeneration, utilizing zeaxanthin, which accumulates in the human eye through a retinal receptor to protect against blue light, oxidative damage, and inflammation associated with macular degeneration. The company's headquarters are located in Honolulu, and it operates within the Health Care sector, specifically in the Pharmaceuticals industry. Cardax Inc's website is https://cardaxpharma.com/. The company is seeking to monetize its pre-clinical candidates, CDX-101 and CDX-301, as it advances its development pipeline. No additional details about the company's financials, specific acquisition history, or other product names are provided in the available information. Cardax is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Cardax stock

Days Inventory Outstanding (DIO) of Cardax is 1,850.69 in 2020.

Days Inventory Outstanding (DIO) of Cardax changed from 1,244.64 to 1,850.69, representing a 48.69% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Days Inventory Outstanding (DIO) Cardax since 2006 – with annual values, charts, and detailed analysis.

DIO measures the average number of days inventory is held before being sold. Lower values indicate more efficient inventory management.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Days Inventory Outstanding (DIO)'s Cardax with sector peers and the industry average to assess whether it is attractive.

To evaluate Days Inventory Outstanding (DIO)'s, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Days Inventory Outstanding (DIO).

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Profitability — Cardax

All Key Metrics — Cardax